Literature DB >> 1315973

The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats.

A Badiani1, J Stewart.   

Abstract

The effect of a systemic (IP) treatment with 1.0, 3.0 and 9.0 mg/kg U-50,488H (U50), a highly selective kappa-agonist, on spontaneous, nocturnal ingestive behavior of the rat was studied using a microcomputer controlled data acquisition system. The latency to initiate drinking was increased and drinking behavior was suppressed in the first hour after injection in a dose-dependent manner. The consummatory indices of drinking were not affected. After this period of adipsia, a phase of polydipsia, that was probably due to the diuretic effect of U50, was evident. This prophagic effect of U50 was evident only at the dose of 3 mg/kg and was accompanied by an increased duration of feeding episodes but not by a reduced latency to feed. These results suggest that kappa-receptors play a pivotal role in modulating spontaneous drinking in the normally hydrated rat and that this control is mainly exerted on the motivational aspect of drinking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315973     DOI: 10.1007/bf02244816

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Effects of intrahypothalamic administration of opioid peptides selective for mu-, kappa, and delta-receptors on different schedules of water intake in the rat.

Authors:  M Ukai; S G Holtzman
Journal:  Brain Res       Date:  1988-09-06       Impact factor: 3.252

2.  An investigation of the role of kappa opiate receptor agonists in the initiation of feeding.

Authors:  J E Morley; A S Levine; M Grace; J Kniep
Journal:  Life Sci       Date:  1982-12-06       Impact factor: 5.037

3.  Parameters of the meal pattern in rats: their assessment and physiological significance.

Authors:  J Le Magnen; M Devos
Journal:  Neurosci Biobehav Rev       Date:  1980       Impact factor: 8.989

4.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

5.  Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey.

Authors:  K W Locke; D R Brown; S G Holtzman
Journal:  Pharmacol Biochem Behav       Date:  1982-12       Impact factor: 3.533

6.  Increased food and water intake produced in rats by opiate receptor agonists.

Authors:  D J Sanger; P S McCarthy
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Further study of kappa opioids on increased urination.

Authors:  J D Leander
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

8.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Opiatergic modulation of preparatory and consummatory components of feeding and drinking.

Authors:  P Nencini; M Graziani
Journal:  Pharmacol Biochem Behav       Date:  1990-11       Impact factor: 3.533

10.  Nor-binaltorphimine decreases deprivation and opioid-induced feeding.

Authors:  A S Levine; M Grace; C J Billington; P S Portoghese
Journal:  Brain Res       Date:  1990-11-26       Impact factor: 3.252

View more
  3 in total

1.  Reduced alcohol consumption in mice lacking preprodynorphin.

Authors:  Yuri A Blednov; Danielle Walker; Marni Martinez; R Adron Harris
Journal:  Alcohol       Date:  2006-10       Impact factor: 2.405

Review 2.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

3.  Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission.

Authors:  P V Piazza; F Rougé-Pont; V Deroche; S Maccari; H Simon; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.